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1015-9584/Copyright ª 2014, Asian SuSummary Background: In Graves’ disease, because a thyroid tends to have extreme vascu-
larity, the amount of intraoperative blood loss (AIOBL) becomes significant in some cases.
We sought to elucidate the predictive factors of the AIOBL.
Methods: A total of 197 patients underwent thyroidectomy forGraves’ disease between2002 and
2012. We evaluated clinical factors that would be potentially related to AIOBL retrospectively.
Results: The median period between disease onset and surgery was 16 months (range: 1e480
months). Conventional surgery was performed in 125 patients, whereas video-assisted surgery
was performed in 72 patients. Subtotal and near-total/total thyroidectomies were performed in
137 patients and 60 patients, respectively. The median weight of the thyroid was 45 g (range:
7.3e480.0 g). Univariate analysis revealed that the strongest correlation of AIOBL was noted with
theweight of thyroid (p< 0.001). Additionally, AIOBLwas correlated positivelywith the period be-
tween disease onset and surgery (p< 0.001) and negatively with preoperative free T4 (p< 0.01).
Multivariate analysis showed that only theweight of the thyroidwas independently correlatedwith
AIOBL (p < 0.001). Four patients (2.0%) needed blood transfusion, including two requiring auto-
transfusion, whose thyroids were all weighing in excess of 200 g. The amount of drainage during
the initial 6 hours and days until drain removal was correlated positively with AIOBL (p < 0.001,
each). Occurrences of postoperative complications, such as recurrent laryngeal nerve palsy or hy-
poparathyroidism, and postoperative hospital stay were not correlated with AIOBL.
Conclusion: Ahugegoiter presentedas apredictive factor for excessive bleedingduring surgery for
Graves’ disease, and preparation for blood transfusion should be considered in cases where thy-
roids weigh more than 200 g.
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Graves’ disease (GD) is an autoimmune disease, in which
thyroid-receptor antibodies combine with the thyrotropin
receptor, promoting the production of thyroid hormones in
the follicular cells through stimulation of cyclic adenosine
monophosphate.1 GD is the most common cause of hyper-
thyroidism. Acceptable therapeutic options are antithyroid
drugs (ATDs), radioiodine (RI) therapy, and surgery.1,2 The
prevalence of therapy varies in different parts of world.
ATDs are the first-line therapy in most of the Japanese pa-
tients, whereas RI is preferred in the United States.1
Although the total number of patients in Japan who
received RI therapy was much fewer than that in Europe or
the United States,3 the application of RI therapy has
extended due to the new regulation that allows its admin-
istration in outpatient clinics.4 Nevertheless, suspicion of
malignancy, unwillingness to receive RI therapy, and preg-
nancy should still be good indications for surgery. Although
thyroidectomy has been regarded as a prompt and assured
therapy for GD, it has some drawbacks, such as operative
scar, need for hospitalization, and complications related to
operation, including recurrent laryngeal nerve (RLN) pa-
ralysis, hypoparathyroidism, and intraoperative bleeding.1,2
Especially in GD, the thyroid gland tends to have hyper-
vascularity, and hemostasis is often difficult.5,6 In this
study, we evaluated the factors that are relevant to the
amount of intraoperative blood loss (AIOBL), and how AIOBL
affects postoperative courses retrospectively.
2. Methods
We reviewed the clinical and laboratory data of 197
consecutive patients with GD, who underwent thyroidec-
tomy between April 2002 and March 2012 at our depart-
ment. Patients who had undergone neck surgery previously
were excluded. GD was defined by the presence of thyro-
toxicosis, a diffuse goiter, and a serum thyroid-stimulating
hormone receptor antibody or thyroid-stimulating anti-
body. After the operation, the diagnosis was confirmed
histologically in all patients. In preparation for surgery, all
patients were given potassium iodide for a median period
of 14 days. Operations were performed with conventional
open surgery or video-assisted neck surgery. The in-
dications and technique of video-assisted neck surgery
were described previously.7 Subtotal thyroidectomy was
defined as leaving between 2 g and 6 g thyroid tissue and
near-total thyroidectomy was defined as leaving < 2 g
thyroid tissue.
We placed closed suction drainage tubes prior to wound
closure in all of the patients except one and removed them
1e3 days later. RLN injury was recorded if voice change was
recognized. Calcium supplements and vitamin D analogs
were given to those with symptomatic hypocalcemia. Pa-
tients who could discontinue the supplements after
achieving normocalcemia within 12 months after surgery
were identified as those with transient hypocalcemia,
whereas patients who had to continue it for more than 12
months and continued to have a below-normal serum intact
parathyroid hormone level were categorized as those with
permanent hypoparathyroidism.Clinical variables were assessed in relation to AIOBL.
Univariate analysis was performed by single regression
analysis to test the correlation between continuous vari-
ables and AIOBL, and Student t test was used to compare
between groups. A p value of <0.05 was considered sta-
tistically significant. For multivariate analysis, the factors
identified as being associated with p  0.10 were entered
into a stepwise regression analysis to determine the inde-
pendent risk factors for AIOBL. Statistical analysis was
performed with StatMate III for Macintosh (ATMS Co., Ltd,
Tokyo, Japan).
3. Results
3.1. Background of patients and operative variables
Background of patients and operative variables are shown in
Table 1. The majority were female (76.1%), with a median
age of 34 years. Themedian period between the onset of the
disease and operation was 16 months. The most frequent
indication for operation was intolerance to ATDs (41.2%),
followed by patient preference (25.4%) and uncontrollable
disease (25.4%). Thirty-seven patients (18.8%) needed pre-
operative adrenocortical hormone administration due to an
excessive value of serum-free T4 even after potassium io-
dide intake. Median intraoperative blood loss was 100 mL
(range: 10e1390 mL), and four patients required blood
transfusion. Thyroidectomy was performed by open surgery
in 125 patients and video-assisted neck surgery in 72 pa-
tients. In terms of the extent of resection, 137 subtotal
thyroidectomies and 60 near-total/total thyroidectomies
were performed. The median weight of thyroid was 45 g
(range: 7e480 g). Transient hypocalcemia was seen in 19.8%
of the patients, but permanent hypoparathyroidism in only
1.0% of patients. RLN palsy was observed in 3.0% of patients,
all of which were temporary. During the study period, we
have not experienced hematoma requiring surgical evacu-
ation. Patients were discharged after their operation within
a median period of 4 days (range: 2e22 days).
3.2. Factors affecting AIOBL
Table 2 shows the correlations between clinical variables
and AIOBL, as shown by univariate analysis. The strongest
correlation of AIOBL was found with the weight of thyroid,
with a correlation coefficient of 0.72 (p < 0.0001). Addi-
tionally, AIOBL was correlated positively with the period
between disease onset and surgery (correlation coefficient
0.36, p< 0.001), and negatively with preoperative free T4 at
the initial consultation (correlation coefficient e0.22,
p < 0.01). Multivariate analysis revealed that only the
weight of the thyroid was correlated with AIOBL (p< 0.0001;
Table 3). Out of four patients who needed intraoperative
blood transfusion (Table 4), two underwent autotransfusion
with preoperatively collected blood.
3.3. Impact of intraoperative blood loss on
postoperative courses
Although AIOBL was correlated positively with the amount
of drainage (correlation coefficient 0.47, p < 0.0001) and
Table 2 Correlation between clinical variables and
intraoperative blood loss (univariate analysis).
Continuous variables
(single regression analysis)
Correlation
coefficient
p
Age (y) 0.08 0.28
BMI 0.05 0.47
Period between disease onset
and surgery
0.35 <0.001
Free T4 at initial consultation 0.22 <0.05
Weight of thyroid 0.72 <0.0001
Categorical variables
(Student t test)
Amount of
bleeding (mL)
p
Sex
Male 120
Female 107 0.55
Operative methods
Open 100
VANS 110 0.1
Type of surgical resection
Subtotal 110
Near total/total thyroidectomy 86 0.51
Weight of thyroid
<100 g* 90
>100 to 200 g** 257
>200 g *** 560
*versus **, p < 0.05.
* versus *** and ** versus ***, p < 0.001.
BMI Z body mass index; VANS Z video-assisted neck surgery.
Table 3 Correlation between clinical variables and
intraoperative blood loss (multivariate analysis).
Multiple regression analysis 95% confidence
interval
p
Period between disease onset
and surgery
0.52e0.25 0.48
Free T4 at initial consultation 12.61e3.8 0.29
Weight of thyroid 1.79e2.48 <0.0001
Table 1 Background of patients and operative variables.
Background of patients
Age (y) 34.0 (11e74)
Sex, male:female 47:150
Period between disease onset and
surgery (mo)
16 (1e480)
Indication for surgery
Intolerance to antithyroid drug 81 (41.2)
Patient preference 50 (25.4)
Uncontrollable disease 50 (25.4)
Large goiter with pressure symptoms 41 (20.8)
Poor adherence 20 (10.2)
Graves’ ophthalmopathy 10 (5.1)
Planned pregnancy 6 (3.0)
Suspicion of malignancy 2 (1.0)
Thyrotoxic crisis 2 (1.0)
Young age 1 (0.5)
Failure of RI therapy 1 (0.5)
Preoperative TSH at initial consultation
(ng/mL)
0.005 (0.0e77.6)
Preoperative free T4 at initial
consultation (ng/mL)
2.6 (0.2e21.3)
Preoperative steroid 37 (18.8)
Preoperative b-blocker 79 (40.1)
Variables of surgery
Duration of surgery (min) 186 (69e380)
Amount of blood loss (mL) 100 (10e1390)
Blood transfusion 4 (2.0)
Operative methods
Open surgery:VANS 125:72
Subtotal:near-total/total
thyroidectomy
137:60
Weight of thyroid (g) 45 (7e480)
Surgical complications
Transient hypocalcemia 40 (19.8)
Permanent hypoparathyroidism 2 (1.0)
Transient RLN palsy 6 (3.0)
Permanent RLN palsy 0 (0.0)
Amount of drainage during initial
6 h (mL)
41 (6e114)
Removal of drain (d) 1 (1e3)
Postoperative hospital stay (d) 4 (2e22)
Data are presented as n (%) or median (range), unless otherwise
indicated.
RI Z radioiodine; RLN Z recurrent laryngeal nerve;
TSH Z thyroid-stimulating hormone; VANS Z video-assisted
neck surgery.
Intraoperative bleeding in Graves’ disease 3the duration of drain retained (correlation coefficient 0.25,
p < 0.001), no correlation was seen between AIOBL and
postoperative hospital stay (Table 5). Furthermore, the
occurrence of postoperative morbidity was not correlated
with AIOBL.
4. Discussion
Thyroidectomy for GD has been one of the acceptable
therapeutic options, although its prevalence differs from
country to country.1 RI therapy is regarded as a safe andeffective therapeutic modality; the majority of patients in
the United States are treated with RI therapy,1,8 which has
become a major therapeutic option in Japan as well. Sur-
gery, however, still plays an important role, and thyroid-
ectomy has certain advantages, such as a rapid therapeutic
effect, a lower recurrence rate than RI therapy or ATDs,8e10
and especially no risk of recurrence after the removal of
the whole gland.9 Moreover, when ATDs are intolerable,
surgery is the only possible therapeutic modality in patients
who are unwilling to receive RI therapy, have Graves’
ophthalmopathy, and are pregnant.1,2
In the present study, a huge goiter was the only clinical
variable that had a positive correlation with AIOBL, as
revealed by multivariate analysis. The thyroid gland in a GD
patient is rich of vascularity and has dilated vessels around
it, and is therefore prone to bleed from the surface or
surrounding vessels.5 Additionally, hemostasis can be
difficult due to the huge size of the goiter, difficulty in
Table 4 Cases with intraoperative blood transfusion.
Case Sex/age (y) Extent of
resection
Weight of
thyroid (g)
Amount of
bleeding
(mL)
Type of
transfusion
1 Female/30 Total 245 550 Auto
2 Male/48 Total 480 1390 Allogeneic
3 Male/23 Subtotal 369 480 Auto
4 Female/53 Total 324 1250 Allogeneic
4 K. Yamanouchi et al.mobilizing the thyroid, reaching vasculatures, and subse-
quently cutting off the inflow of blood.
We experienced two cases of permanent hypoparathy-
roidism (1.0%) and no permanent RLN palsy postoperatively,
whose rates were comparable to those of previous re-
ports.2,9,11 Because the number of patients with these
permanent complications was very small to address statis-
tical evaluation, we evaluated transient complications in
this study. Among benign goiter surgeries, GD itself was
shown as an independent risk factor for either post-
operative transient hypoparathyroidism12 or RLN palsy.13 In
our study, AIOBL was not related to the complications, and
that might be the reason why no correlation was found
between AIOBL and postoperative stay.
Continued growth of a Graves’ goiter in a patient on
ATDs and increasing the difficulty of a delayed thyroidec-
tomy were reported previously.2 In our analysis, the disease
period was correlated positively with the weight of the
thyroid and inversely with free T4 levels, according to
univariate analysis (data not shown). This implied that the
indication for thyroidectomy changed with the course of
the disease; for example, although patients with a short
term of disease tended to undergo thyroidectomy due to
functional issues, those suffering from the disease for a
long period of time underwent surgery due to other rea-
sons, such as huge goiter and Graves’ ophthalmopathy,
even when function was controlled by ATDs. Several ran-
domized trials showed that administration of ATDs for more
than 18 months did not improve the remission rate.14e16Table 5 Impact of blood loss on perioperative courses.
Continuous variables
(single regression analysis)
Correlation
coefficient
p
Amount of drainage during initial 6 h 0.47 <0.0001
Duration of drain retained (d) 0.25 <0.001
Postoperative hospital stay (d) 0.05 0.48
Categorical variables
(Student t test)
Amount of
bleeding (mL)
p
Surgical complications
Transient hypocalcemia
Yes 110
No 100 0.67
Transient RLN palsy
Yes 80
No 100 0.15
RLN Z recurrent laryngeal nerve.Although Erbil et al17 showed a negative correlation be-
tween ADT treatment duration and AIOBL by multivariate
analysis, our result was the opposite, according to univar-
iate analysis, even though most of our patients took ATDs at
the time of operation. The reason for this discrepancy was
not defined; according to our results, definitive therapy
should be considered after a couple of years of ATD ther-
apy, not only from the aspect of remission rate but also the
safety on operation.
Four out of 11 cases with thyroids weighing more than
200 g underwent intraoperative blood transfusion (data not
shown). We could not evaluate the vascularity, which was
reported to affect AIOBL,17 in all cases because it was a
retrospective study. We believe that further prospective
examinations may find a notable formula that predicts
AIOBL more accurately. Regardless of this limitation, our
results recommend that preparation for blood transfusion
should be made in GD patients with a huge goiter estimated
to weigh more than 200 g.References
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